Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals.
about
Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherenceDeveloping an HbA(1c)-based equation to estimate blood glucose in maintenance hemodialysis patients.Management of mineral and bone disorder after kidney transplantation.The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.Towards the revival of alkaline phosphatase for the management of bone disease, mortality and hip fractures.Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients.Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part DInsights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patientsComparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis.Serum vitamin D and parathyroid hormone profiles in patients with various stages of renal diseaseImpact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients.Vitamin D safety and requirements.Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT studyAnalysis of the kinetics of the parathyroid hormone, and of associated patient outcomes, in a cohort of haemodialysis patients.Differentially expressed miR-3680-5p is associated with parathyroid hormone regulation in peritoneal dialysis patients.Rapid decrease of intact parathyroid hormone could be a predictor of better response to cinacalcet in hemodialysis patients.Mineral and bone disease in black african hemodialysis patients: a report from senegalSurvival disparities within American and Israeli dialysis populations: learning from similarities and distinctions across race and ethnicity.Association of aspartate aminotransferase with mortality in hemodialysis patients.Correlates of parathyroid hormone concentration in hemodialysis patients.Successful Conversion From Parenteral Paricalcitol to Pulse Oral Calcitriol for the Management of Secondary Hyperparathyroidism in Hemodialysis Patients.Vitamin D status in children with chronic kidney diseasePlacental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease--a prospective observational study.Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical populationUsing hemoglobin A1c to derive mean blood glucose in peritoneal dialysis patients.A systems biology preview of the relationships between mineral and metabolic complications in chronic kidney disease.Genetic polymorphisms of ORAI1 and chronic kidney disease in Taiwanese population.Mineral metabolism and vitamin D in chronic kidney disease--more questions than answers.The role of vitamin D deficiency in cardiovascular disease: where do we stand in 2013?Osteoporosis after renal transplantation.Vitamin D supplements in chronic kidney disease.Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis.Positioning novel biologicals in CKD-mineral and bone disorders.αKlotho and Chronic Kidney Disease.The Relation Between Variability of Intact Parathyroid Hormone, Calcium, and Cardiac Mortality in Hemodialysis Patients.Whole body calcification in a hemodialysis patient.Antilipolytic effect of calcimimetics depends on the allelic variant of calcium-sensing receptor gene polymorphism rs1042636 (Arg990Gly).Parameters of mineral metabolism predict midterm clinical outcome in end-stage heart failure patients.Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients.Coronary risk score for mineral bone disease in chronic non-diabetic hemodialysis patients: results from a prospective pilot study.
P2860
Q27013882-B3C89848-96E5-41FC-A881-99265A7D37F2Q30413995-E2EEA2B1-DBAA-49C9-9CC2-9044C2E88E2DQ30418461-FB1BD4B8-CC2E-407E-97B4-5FCDB902FFF0Q30524695-5C14FC22-FBB2-4DA8-B660-85F5489BCBA5Q33932610-E85F9BD1-6F87-4D62-8DD1-DDE240E54D22Q34135288-83F29666-F802-4544-A64E-102219123FC4Q34403806-CCF3F165-CAC7-43DC-A13B-75BE7C34272DQ34545929-79351435-CC1A-45D4-B5C3-2DBDE0A9BB31Q34725113-E39D0135-1721-4BDD-8A86-DB55482CECF9Q35160399-3759B316-1CBA-446B-BD53-C02F11347475Q35229831-B535DC6A-FEF4-4057-9F8A-56F8CFF881BFQ35850965-9531356F-D731-48B0-AC02-83E8A8D92A60Q36129859-725A5DE3-4B2B-444C-9B41-04FB51389A0BQ36166690-2F8CC33B-EB71-4F3B-8D3F-C942E075BD87Q36267767-7733A420-54BB-46A5-93E2-A0C172F558F8Q36620322-7440813D-168A-4073-B309-72E83412DA27Q36734438-5D8655AA-12F5-4CAF-83E5-9B32DAF6020AQ36746271-EBDE6667-C00B-4E46-89FC-F5A05CABE245Q36846539-12FA7087-DD1F-4B74-9E60-DBE43E0EBB46Q36936601-9AB69EA2-DE78-4132-B6E5-4310FB2874AFQ37018411-43B41F01-3C69-4303-8661-921A5E2F1CA4Q37109797-1EF0C6B2-6456-466B-90E2-7E9B4266F8B7Q37113344-4A430E70-763D-4BA7-B22A-769FEA36BAA3Q37198454-AD12EFAB-3990-4B63-B6AF-3CB970D790A4Q37352182-05B1CDAC-D82B-4AB6-9C96-8E83C0FB44C6Q37365294-0E25A061-7464-45F5-A8D7-BD704EB71519Q37686687-A910B4C2-A86F-436D-B48B-6D0D3EDD29E9Q37871341-B86BFBAD-AD67-4CE3-8F5A-5A119FE4CE44Q38156665-0905CEDA-7FF3-4879-94AF-17F7AC196916Q38266612-644C76C9-9455-4501-9AF6-807C864CE210Q38554471-F7D18226-9735-4787-A5DF-523DCA9E5BAAQ39056902-87A40F6F-984B-4C22-A474-082D336B7E4DQ39328170-D6EB9FD1-1852-48DD-9600-83581B5CFCC1Q39812781-200E6599-4FA5-4FE4-BE82-ED2A3DBBCE34Q40783524-1ED496EE-0609-44CF-BCA4-8E1D0CC03F58Q41270639-5C6B3741-ED7C-4139-A7B9-97E93158F734Q42498894-3364A1D3-4315-44B4-BE2E-9987759D605FQ45032525-2859854A-ADA1-45D9-8101-13EBEE577E0EQ47789778-618F1A99-748D-4F3A-ACE6-AE4384CD64E9Q50531502-07CDD50B-658F-4094-871D-A8BF3C1A2659
P2860
Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Kidney bone disease and mortal ...... ine phosphatase, and minerals.
@ast
Kidney bone disease and mortal ...... ine phosphatase, and minerals.
@en
type
label
Kidney bone disease and mortal ...... ine phosphatase, and minerals.
@ast
Kidney bone disease and mortal ...... ine phosphatase, and minerals.
@en
prefLabel
Kidney bone disease and mortal ...... ine phosphatase, and minerals.
@ast
Kidney bone disease and mortal ...... ine phosphatase, and minerals.
@en
P2093
P2860
P356
P1476
Kidney bone disease and mortal ...... ine phosphatase, and minerals.
@en
P2093
Anuja Shah
Ramanath Dukkipati
Rulin C Hechter
Uyen Duong
P2860
P304
P356
10.1038/KI.2010.189
P577
2010-08-01T00:00:00Z